(Q35148049)

6 August 2017

title

Basal cell carcinoma: an evidence-based treatment update (English)

1 reference

6 August 2017

Charlotte M Clark

1

1 reference

6 August 2017

Megan Furniss

series ordinal

2

1 reference

6 August 2017

Julian M Mackay-Wiggan

series ordinal

3

1 reference

6 August 2017

publication date

1 July 2014

1 reference

American Journal of Clinical Dermatology

6 August 2017

published in

1 reference

6 August 2017

volume

15

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

197-216

1 reference

Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Basal cell carcinoma: treatment options and prognosis, a scientific approach to a common malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

The Development of Clinical Practice Guidelines and Guidance Statements of the American College of Physicians: Summary of Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

A randomized parallel study to assess the safety and efficacy of two different dosing regimens of 5% imiquimod in the treatment of superficial basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

A pilot study to evaluate the treatment of basal cell carcinoma with 5-fluorouracil using phosphatidyl choline as a transepidermal carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Solasodine glycoalkaloids: a novel topical therapy for basal cell carcinoma. A double-blind, randomized, placebo-controlled, parallel group, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

A systematic review of treatment modalities for primary basal cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Histology-based treatment of basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

Basal cell carcinoma: evidence-based medicine and review of treatment modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0070-Z

10.1007/S40257-014-0070-Z

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference